Immunic Inc. Stock
Immunic Inc. Stock
We can see a decrease in the price for Immunic Inc.. Compared to yesterday it has lost -€0.016 (-1.250%).
Currently there is a rather positive sentiment for Immunic Inc. with 6 Buy predictions and 3 Sell predictions.
With a target price of 5 € there is potential for a 298.72% increase which would mean more than doubling the current price of 1.25 € for Immunic Inc..
So far the community has only identified positive things for Immunic Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Immunic Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immunic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | -1.250% | 9.711% | 5.734% | -16.511% | -12.308% | -87.269% | - |
| Ocuphire Pharma Inc. | 2.500% | 20.930% | 8.208% | -66.750% | -33.023% | - | - |
| NanoViricides Inc. | 1.980% | 0.000% | -20.155% | -5.505% | 8.995% | -65.459% | -74.890% |
| Synthetic Biologics Inc. | 1.050% | 0.637% | -2.589% | -39.695% | -1.250% | -89.660% | -92.100% |
Comments
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for IMUX provided by MarketBeat